Ian D. Dang

Array ( [id] => 8063757 [patent_doc_number] => 20110245145 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-06 [patent_title] => 'METHODS AND REAGENTS FOR THE DIAGNOSIS, PREVENTION AND TREATMENT OF INSULIN RESISTANCE' [patent_app_type] => utility [patent_app_number] => 13/132750 [patent_app_country] => US [patent_app_date] => 2009-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 12468 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0245/20110245145.pdf [firstpage_image] =>[orig_patent_app_number] => 13132750 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6245669 [patent_doc_number] => 20100136007 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-03 [patent_title] => 'CSF1R EXTRACELLULAR DOMAIN FUSION MOLECULES AND TREATMENTS USING SAME' [patent_app_type] => utility [patent_app_number] => 12/626598 [patent_app_country] => US [patent_app_date] => 2009-11-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 24425 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0136/20100136007.pdf [firstpage_image] =>[orig_patent_app_number] => 12626598 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8543372 [patent_doc_number] => 08318663 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-11-27 [patent_title] => 'Methods of treating diabetes and/or obesity using an enteroendocrine peptide secretion enhancing agent' [patent_app_type] => utility [patent_app_number] => 12/624345 [patent_app_country] => US [patent_app_date] => 2009-11-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 17 [patent_no_of_words] => 25600 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 83 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12624345 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9112538 [patent_doc_number] => 08568706 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-10-29 [patent_title] => 'Modified human interferon-beta polypeptides' [patent_app_type] => utility [patent_app_number] => 12/610909 [patent_app_country] => US [patent_app_date] => 2009-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 16 [patent_no_of_words] => 65289 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12610909 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6417912 [patent_doc_number] => 20100167331 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-01 [patent_title] => 'ASSESSING RISK OF CARDIAC INTERVENTION IN PATIENTS SUFFERING FROM STABLE CORONARY HEART DISEASE BASED ON GDF-15' [patent_app_type] => utility [patent_app_number] => 12/577755 [patent_app_country] => US [patent_app_date] => 2009-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8170 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0167/20100167331.pdf [firstpage_image] =>[orig_patent_app_number] => 12577755 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8146704 [patent_doc_number] => 08163717 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-04-24 [patent_title] => 'Dual chain synthetic heparin-binding growth factor analogs' [patent_app_type] => utility [patent_app_number] => 12/574484 [patent_app_country] => US [patent_app_date] => 2009-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13273 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/163/08163717.pdf [firstpage_image] =>[orig_patent_app_number] => 12574484 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6360805 [patent_doc_number] => 20100087532 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-08 [patent_title] => 'MODULATION OF SIGNAL TRANSDUCTION' [patent_app_type] => utility [patent_app_number] => 12/567563 [patent_app_country] => US [patent_app_date] => 2009-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 13597 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0087/20100087532.pdf [firstpage_image] =>[orig_patent_app_number] => 12567563 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7487523 [patent_doc_number] => 20110236412 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-29 [patent_title] => 'Method for Preserving Polypeptides Using a Sugar and Polyethyleneimine' [patent_app_type] => utility [patent_app_number] => 13/120539 [patent_app_country] => US [patent_app_date] => 2009-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 29798 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0236/20110236412.pdf [firstpage_image] =>[orig_patent_app_number] => 13120539 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6220006 [patent_doc_number] => 20100055101 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-04 [patent_title] => 'CYTOKINE RECEPTOR ZCYTOR17 MULTIMERS' [patent_app_type] => utility [patent_app_number] => 12/545770 [patent_app_country] => US [patent_app_date] => 2009-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 85854 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0055/20100055101.pdf [firstpage_image] =>[orig_patent_app_number] => 12545770 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5368433 [patent_doc_number] => 20090305992 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-10 [patent_title] => 'USE OF AN INTERLEUKIN 1 RECEPTOR ANTAGONIST AND/OR PYRROLIDINEDITHIOCARBAMATE FOR THE TREATMENT OR PROPHYLAXIS OF TYPE 2 DIABETES' [patent_app_type] => utility [patent_app_number] => 12/538831 [patent_app_country] => US [patent_app_date] => 2009-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 18997 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0305/20090305992.pdf [firstpage_image] =>[orig_patent_app_number] => 12538831 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8177287 [patent_doc_number] => 08178495 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-05-15 [patent_title] => 'Therapeutic agents comprising a GLP-1 receptor agonist and elastin-like peptide' [patent_app_type] => utility [patent_app_number] => 12/493912 [patent_app_country] => US [patent_app_date] => 2009-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 23 [patent_no_of_words] => 69014 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/178/08178495.pdf [firstpage_image] =>[orig_patent_app_number] => 12493912 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6544025 [patent_doc_number] => 20100016227 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-21 [patent_title] => 'LIGAND/LYTIC PEPTIDE COMPOSITIONS AND METHODS OF USE' [patent_app_type] => utility [patent_app_number] => 12/488353 [patent_app_country] => US [patent_app_date] => 2009-06-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14367 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0016/20100016227.pdf [firstpage_image] =>[orig_patent_app_number] => 12488353 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6356142 [patent_doc_number] => 20100086946 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-08 [patent_title] => 'PLGF, FLT1 AND ENDOGLIN FOR DIAGNOSING ANGIOGENIC STATUS IN CORONARY ARTERY DISEASE' [patent_app_type] => utility [patent_app_number] => 12/487126 [patent_app_country] => US [patent_app_date] => 2009-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7690 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0086/20100086946.pdf [firstpage_image] =>[orig_patent_app_number] => 12487126 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5484929 [patent_doc_number] => 20090274694 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-05 [patent_title] => 'CYTOKINE RECEPTOR ZCYTOR17 MULTIMERS' [patent_app_type] => utility [patent_app_number] => 12/484019 [patent_app_country] => US [patent_app_date] => 2009-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 85822 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0274/20090274694.pdf [firstpage_image] =>[orig_patent_app_number] => 12484019 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5986657 [patent_doc_number] => 20110098226 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-28 [patent_title] => 'Small molecular weight TNF receptor multimeric molecule' [patent_app_type] => utility [patent_app_number] => 12/455977 [patent_app_country] => US [patent_app_date] => 2009-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 6124 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0098/20110098226.pdf [firstpage_image] =>[orig_patent_app_number] => 12455977 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7523059 [patent_doc_number] => 08026215 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-09-27 [patent_title] => 'Methods and compositions for control of fetal growth via modulation of relaxin' [patent_app_type] => utility [patent_app_number] => 12/475405 [patent_app_country] => US [patent_app_date] => 2009-05-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 32413 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/026/08026215.pdf [firstpage_image] =>[orig_patent_app_number] => 12475405 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6083588 [patent_doc_number] => 20110144009 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-16 [patent_title] => 'Brown Adipocyte Progenitors in Human Skeletal Muscle' [patent_app_type] => utility [patent_app_number] => 12/994590 [patent_app_country] => US [patent_app_date] => 2009-05-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 11024 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0144/20110144009.pdf [firstpage_image] =>[orig_patent_app_number] => 12994590 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9286213 [patent_doc_number] => 08642542 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-02-04 [patent_title] => 'Recombinant fusion proteins to growth hormone and serum albumin' [patent_app_type] => utility [patent_app_number] => 12/471168 [patent_app_country] => US [patent_app_date] => 2009-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 6992 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 110 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12471168 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9286213 [patent_doc_number] => 08642542 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-02-04 [patent_title] => 'Recombinant fusion proteins to growth hormone and serum albumin' [patent_app_type] => utility [patent_app_number] => 12/471168 [patent_app_country] => US [patent_app_date] => 2009-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 6992 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 110 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12471168 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6256830 [patent_doc_number] => 20100029562 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-04 [patent_title] => 'hG31P Expression System' [patent_app_type] => utility [patent_app_number] => 12/470275 [patent_app_country] => US [patent_app_date] => 2009-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 15013 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0029/20100029562.pdf [firstpage_image] =>[orig_patent_app_number] => 12470275 [rel_patent_id] =>[rel_patent_doc_number] =>)